currently , production volumes have fallen 10 times. states natalia fedosova. the logistics are broken, it is not possible to send biomaterial. in order to receive an antitumor vaccine produced at the national cancer institute, the patient must come in person, because here they use a different production technology than at the kavetsky institute. in addition to a part of the tumor, the patient's blood is required. blood is collected, peripheral, 50 ml. and over the course of eight days, we grow already mature dendritic cells, these are specific cells in body, which teach the rest of the cells of the immune system to recognize tumor cells. the cost of vaccination is about uah 30,000. in european countries, where anticancer vaccines are used, this cost is ten times higher, - says oleksandr horbach. at the cancer institute , the immunobiological drug is not sold due to the lack of registration, so the patient can be offered vaccination only during scientific research, free of charge, if the institute finds sponsors for the project. within the framework of scientif